Please assess the completion status of the following clinical trial:

Trial Title: Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Imaging and tissue diagnosis of recurrent or progressive nasopharyngeal carcinoma~* Documentation of previous treatment including conventional chemotherapy and/or radiation therapy as clinically appropriate~* Ages 2 to 30 years of age~* Negative serum pregnancy test if applicable~* Calculated creatinine clearance of greater than 60 mL/minute, serum creatinine of less than 12o micromoles/L, total bilirubin less than 2 mg/dL and aspartate aminotransferase (AST) must be less than twice the upper limit of normal~Exclusion Criteria:~* Unsuitable candidate for autologous transplantation due to comorbidities or intractable psychosocial issues~* Pregnancy~* Breast-feeding women

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 30 Years
- Healthy Volunteers: f

Study Arms:
- High Dose Conditioning (Type: EXPERIMENTAL): Single arm - receives high dose Etoposide phosphate, Ifosfamide, and Carboplatin followed by Autologous Stem Cell Transplantation

Based on this trial design, predict the completion outcome and termination type (if applicable).